Stay updated on Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site as revision v3.7.2.SummaryDifference0.1%

- Check12 days agoChange DetectedThe ClinicalTrials.gov site footer revision identifier changed from v3.7.0 to v3.7.1. The study record content remains unchanged.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedA new revision tag v3.7.0 was added and the previous tag v3.6.6 was removed, signaling an update to the study record's version.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing v3.6.5, indicating a new version of the page in the history.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision entry, v3.6.5, was added to the study record history and the previous revision, v3.6.4, was removed. This update represents changes to the page’s versioning metadata rather than alterations to the study data.SummaryDifference0.1%

- Check90 days agoChange DetectedThe history page now reflects Revision: v3.6.4 instead of v3.6.3. This indicates a new software revision was applied to the Record History page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.